Segmed partners with Verily to expand access to real-world imaging data for precision health research and AI development. The collaboration enables researchers to explore curated, de-identified imaging datasets within Verily’s secure research environments.
Through this agreement, Segmed, Inc. is making its diagnostic-grade imaging and associated clinical data available via Verily’s Pre Exchange and Workbench platforms. These secure tools are designed to accelerate precision health discovery while maintaining strict privacy standards.
Expanding Real-World Imaging Data for Precision Health
Real-world imaging data plays a critical role in modern healthcare research. When combined with clinical and biomedical datasets, imaging data strengthens AI model development and diagnostic innovation.
By integrating its datasets into Verily’s precision health platform, Segmed lowers barriers for researchers across academia, life sciences, and healthcare AI. As a result, investigators gain streamlined access to multimodal datasets within a trusted, privacy-first environment.
Breast Cancer Dataset Available on Pre Exchange
Segmed’s initial dataset available through Pre Exchange focuses on breast cancer research. It includes a longitudinal cohort of patients who underwent at least one digital breast tomosynthesis (DBT) exam and had biopsy-proven malignant lesions.
This curated dataset is drawn from Segmed’s global imaging platform, which contains approximately 150 million de-identified imaging exams. These span modalities such as CT, MRI, X-ray, ultrasound, mammography, PET, SPECT, echocardiography, and DEXA.
Therefore, researchers can leverage high-quality, real-world imaging data to improve AI-driven diagnostics and clinical research outcomes.
Supporting AI-Powered Precision Medicine
David Gascoigne, CEO of Segmed, emphasized that advanced imaging data is essential for precision medicine. He noted that combining imaging with clinical and biomedical data accelerates insights and supports the development of new diagnostics and therapies.
Similarly, Bharat Rajagopal, Chief Revenue Officer at Verily, stated that integrating Segmed’s curated datasets strengthens AI-powered precision health initiatives. By embedding multimodal imaging data into the Pre platform, researchers can unlock deeper insights and drive faster discovery.
Advancing Secure and Scalable Research
Importantly, this partnership underscores a shared commitment to privacy-first research. All datasets are de-identified and delivered within secure research environments.
As healthcare innovation becomes increasingly data-driven, secure access to real-world imaging data is vital. Consequently, the Segmed and Verily collaboration supports scalable, patient-centered research across global institutions.
Overall, the partnership marks another step toward accelerating AI-enabled precision health through responsible access to real-world imaging and clinical data.
Read Also: CSX Data Modernization with Infosys and Microsoft Transforms Rail Analytics
